1. OBJECTS IN MIRROR ARE CLOSER THAN THEY APPEAR Looking Back at Mycobacterium tuberculosis Mouse Efficacy Testing To Move New Drugs Forward Sean Ekins1,2, Robert C. Reynolds3…

1. Why Are We Still Doing Industrial Age Drug Discovery For Neglected Diseases in The Information Age?Sean EkinsCollaborations In Chemistry, Fuquay Varina, NC 2. Some Technologies…

Slide 1Edward Nardell, MD Brigham & Womens Hospital Division of Global Health Equity Pulmonary Division Harvard Medical School Harvard School of Public Health Partners…

Slide 1 INSA INSTITUTO NACIONAL de SAÚDE DR. RICARDO JORGE DDI Departamento de Doenças Infecciosas Slide 2 Jaime Nina Co. DDI Slide 3 DDI : a experiência do Passado para…

Slide 1 Why Are We Still Doing Industrial Age Drug Discovery For Neglected Diseases in The Information Age? Sean Ekins Collaborations In Chemistry, Fuquay Varina, NC Slide…

Slide 1 TUBERCOLOSIS Agis Terzidis, Paediatrician Spyridon Gialamas, Medical Doctor SEMINAR ON TROPICAL AND TRAVEL MEDICINE AT TTCIH IFAKARA 25 JUNE 2009 Slide 2 Estimated…

Why Are We Doing Industrial Age Drug Discovery in The Information Age Why Are We Still Doing Industrial Age Drug Discovery For Neglected Diseases in The Information Age?…

Statistical & Design Considerations for Non-inferiority trials Andrew Nunn MRC Clinical Trials Unit London TB Forum December 2005 Outline What is a non-inferiority trial?…

WHO/HTM/TB/2015.28 Active tuberculosis drug-safety monitoring and management (aDSM) Framework for implementation November 2015 Active tuberculosis drug-safety monitoring…

Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004 Paris, France I am…